As reported by the Drug & Device Law Blog 

“A week ago, in a post-script to a post on Daubert decisions, we reported that the trial court in Hexum v. Eli Lilly & Co., No. 2:13-cv-02701-SVM-MAN, 2015 U.S. Dist. LEXIS 109737 (C.D. Cal. Aug. 18, 2015), had granted directed verdict at the end of plaintiffs’ case.  Our readers may have noticed that we (in both the singularly singular and common plural sense of the word) have a thing for proximate cause for failure to warn, which was why the defendant won in Hexum.  So, we decided to somewhat deeper dive on why the defendant drug manufacturer won and whether there are lessons to be learned.”

Read More Orange



Related HB program

Drug & Device Defense Forum